HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hofele, K. Articles by Auburger, G. Search for Related Content PubMed PubMed Citation Articles by Hofele, K. Articles by Auburger, G.

Gene locus FPD1 of the dystonic Mount-Reback type of autosomal-dominant paroxysmal choreoathetosis

From the Departments of Neurology, University Hospitals of Düsseldorf(K. Hofele and Dr. Auburger) and Rostock (Dr. Benecke), Germany.

Address correspondence and reprint requests to Dr. Georg Auburger, Dept. Neurology, University Hospital, P.O. Box 101007, 40001 Düsseldorf, Germany.

Genes for paroxysmal choreoathetosis have been localized to chromosomes 1p and 2q. We have reinvestigated one of the classic large autosomal-dominant pedigrees of the dystonic Mount-Reback type of paroxysmal choreoathetosis 20 years after its first assessment. These patients prefer diazepam for both prevention and treatment of attacks and did not develop addiction on an intermittent regime. Migraine occurred in a third of the patients. Genetic data localized the underlying mutation to the FPD1 locus (familial paroxysmal dyskinesia type 1) on chromosome 2q and support locus homogeneity for the Mount-Reback syndrome. The data also refine the FPD1 candidate region to 3.6 cM between the markers D2S164 and D2S2359, which may facilitate the investigation of the role of the candidate ion channel gene SLC2C.

Supported by the BMBF grant 01KL9001/26-21 and the BMFZ Düsseldorf.

Received March 19, 1997. Accepted in final form June 3, 1997.

This article has been cited by other articles:

				I. Unterberger and E. Trinka Review: Diagnosis and treatment of paroxysmal dyskinesias revisited Therapeutic Advances in Neurological Disorders, September 1, 2008; 1(2): 67 - 74. [Abstract] [PDF]

				D.-H. Chen, M. Matsushita, S. Rainier, B. Meaney, L. Tisch, A. Feleke, J. Wolff, H. Lipe, J. Fink, T. D. Bird, et al. Presence of Alanine-to-Valine Substitutions in Myofibrillogenesis Regulator 1 in Paroxysmal Nonkinesigenic Dyskinesia: Confirmation in 2 Kindreds Arch Neurol, April 1, 2005; 62(4): 597 - 600. [Abstract] [Full Text] [PDF]

				H.-Y. Lee, Y. Xu, Y. Huang, A. H. Ahn, G. W.J. Auburger, M. Pandolfo, H. Kwiecinski, D. A. Grimes, A. E. Lang, J. E. Nielsen, et al. The gene for paroxysmal non-kinesigenic dyskinesia encodes an enzyme in a stress response pathway Hum. Mol. Genet., December 15, 2004; 13(24): 3161 - 3170. [Abstract] [Full Text] [PDF]

				S. Rainier, D. Thomas, D. Tokarz, L. Ming, M. Bui, E. Plein, X. Zhao, R. Lemons, R. Albin, C. Delaney, et al. Myofibrillogenesis Regulator 1 Gene Mutations Cause Paroxysmal Dystonic Choreoathetosis Arch Neurol, July 1, 2004; 61(7): 1025 - 1029. [Abstract] [Full Text] [PDF]

				A Münchau, E M Valente, G A Shahidi, L H Eunson, M G Hanna, N P Quinn, A H V Schapira, N W Wood, and K P Bhatia A new family with paroxysmal exercise induced dystonia and migraine: a clinical and genetic study J. Neurol. Neurosurg. Psychiatry, May 1, 2000; 68(5): 609 - 614. [Abstract] [Full Text]

				H. Matsuo, K. Kamakura, M. Saito, M. Okano, T. Nagase, Y. Tadano, K.-i. Kaida, A. Hirata, N. Miyamoto, T. Masaki, et al. Familial Paroxysmal Dystonic Choreoathetosis: Clinical Findings in a Large Japanese Family and Genetic Linkage to 2q Arch Neurol, June 1, 1999; 56(6): 721 - 726. [Abstract] [Full Text] [PDF]